•A meta-analysis of the effects of proton pump inhibitors on the risk of gastric cancer
•Association between antibody-mediated immune responses and gastroesophageal reflux disease: Evidence from genetic studies
•Identification of potential drug targets for achalasia from genetic insights: a Mendelian randomization study
•Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells
•Positional effects on gastric pressures and esophagogastric pressure gradients in patients with gastroesophageal reflux